Interested to Buy Any Domain ? << Click Here >> for more details...
In Stability testing if significant change occur then what
is the action plan?
- 4 Answers
- 26080 Views
- Bliss GVS Pharma, MSN Pharma, I also Faced
- E-Mail Answers
Answer Posted / sitaramaraju kantasputhy
If it is at Development stage, then Formulation change or packaging change shall be done
If it at Exhibit batch study,then that should be addressed as OOT/OOS and same should be investigated.Then shall go for change in formulation or packaging
If it is at commercial batches then same should be addressed as OOS/OOT and should investigated.based on study product should recall.
| Is This Answer Correct ? | 26 Yes | 1 No |
Post New Answer View All Answers
What is difference between assay and content uniformity ?
what are all the parameters to be considered while applying bracketing and matrixing?where and all it is applicable?
How to select temperature of ODT in disintegration test
How would you manage your team for pahrmaceutical representatives?
what is the difference of vaccum pressure and vapour pressure ?
how quantitative stability studies are done?
define the starting material?
How to conduct Literature Survey for Generics Development for European Market
What are the common indications for prescribing Alprazolam? How does it differ from other medications used to treat anxiety?
why u want to join as a m.r?
How would you propose to advertise your drug?
how to make Enrofloxacin 20% solution & whats remedy to avoid crystal formation in this batch after 15 -20days? Please anybody assist in it
i like to know when is drug inspector exam 2009.and plz send me da question paper, interviev questions,and other details on my mail.id. shubhg2009@gmail.com. plz
how related substnce method developted for new compound which not official in the pharmacopiea
how impurity is analyzed in a tablet
